Global Financial Private Capital LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,234 shares of the healthcare conglomerate’s stock after buying an additional 826 shares during the quarter. Global Financial Private Capital LLC’s holdings in UnitedHealth Group were worth $2,268,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in UNH. Groesbeck Investment Management Corp NJ grew its position in UnitedHealth Group by 4.0% during the first quarter. Groesbeck Investment Management Corp NJ now owns 34,342 shares of the healthcare conglomerate’s stock valued at $5,632,000 after buying an additional 1,314 shares during the period. Founders Capital Management acquired a new stake in UnitedHealth Group during the first quarter valued at $135,000. Independent Advisor Alliance grew its position in UnitedHealth Group by 10.4% during the first quarter. Independent Advisor Alliance now owns 16,136 shares of the healthcare conglomerate’s stock valued at $2,668,000 after buying an additional 1,525 shares during the period. 1st Global Advisors Inc. grew its position in UnitedHealth Group by 32.1% during the first quarter. 1st Global Advisors Inc. now owns 23,163 shares of the healthcare conglomerate’s stock valued at $3,799,000 after buying an additional 5,624 shares during the period. Finally, Beacon Trust Co. grew its position in UnitedHealth Group by 5.6% during the first quarter. Beacon Trust Co. now owns 43,322 shares of the healthcare conglomerate’s stock valued at $7,164,000 after buying an additional 2,300 shares during the period. Institutional investors own 86.20% of the company’s stock.
UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.39 on Monday, reaching $226.78. 3,326,000 shares of the company were exchanged, compared to its average volume of 3,107,989. The firm has a market capitalization of $219,765.13, a price-to-earnings ratio of 23.62, a PEG ratio of 1.68 and a beta of 0.66. UnitedHealth Group Incorporated has a 52-week low of $156.09 and a 52-week high of $229.22. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold 63,206 shares of company stock worth $12,683,669 over the last ninety days. 0.89% of the stock is owned by insiders.
UNH has been the topic of several analyst reports. UBS restated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reiterated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $224.56.
TRADEMARK VIOLATION NOTICE: This news story was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://weekherald.com/2017/12/04/global-financial-private-capital-llc-has-2-27-million-position-in-unitedhealth-group-incorporated-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.